How to Buy 4d Molecular Therapeutics Stock
4d Molecular Therapeutics Inc
4D Molecular Therapeutics, Inc. , a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors.
4d Molecular Therapeutics stock last closed at $3.24, down 2.99% from the previous day, and has decreased 86.64% in one year. It has underperformed other stocks in the Biotechnology industry by 0.09 percentage points. 4d Molecular Therapeutics stock is currently +44.97% from its 52-week low of $2.24, and -88.8% from its 52-week high of $28.93.
As of Apr 29, 2025, there are 46.3M shares of FDMT outstanding. The market cap of FDMT is $150.02M. In the past 24 hours, 354,813 FDMT shares were traded.
How to Buy 4d Molecular Therapeutics Stock
Wondering how to invest in 4d Molecular Therapeutics stock? Here's how.
- Decide where to buy 4d Molecular Therapeutics stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you figure out where to buy 4d Molecular Therapeutics stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Put funds into your brokerage account: Choose your payment method and add your details.
- Analyze 4d Molecular Therapeutics stock: The 4d Molecular Therapeutics ticker symbol is FDMT. Is 4d Molecular Therapeutics stock a good investment? Should you buy shares of FDMT? How do FDMT's underlying business fundamentals look? Do top analysts think 4d Molecular Therapeutics is a good buy? Why has FDMT's stock price moved recently? (Hint: Our stock research website can help you evaluate if FDMT is a good stock to buy).
- Make your FDMT trade: Decide if you will purchase FDMT shares at the current market price or use a limit order to buy FDMT stock at a specific price.
- Get the latest news on your FDMT investment: Create a watchlist to important notifications about your position in 4d Molecular Therapeutics stock.
Step 1: Decide where to buy 4d Molecular Therapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy FDMT stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Tech to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked the best brokerage, you'll need to fill out some personal information so you can invest in FDMT today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to open a new brokerage account.
- Send your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you've filled out your info on the best stock buying app, your next step is to transfer the money for your investment:
Watch this video walkthrough if you need help depositing money into your new investment account.
Step 4: Analyze 4d Molecular Therapeutics stock
After you have chosen the best place to buy 4d Molecular Therapeutics stock, it's critical to research their stock before you invest, so you can wrap your head around the risk and upside.
4d Molecular Therapeutics stock data
FDMT Due Diligence Score
WallStreetZen was designed to help part-time investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on FDMT's stock page.
Is FDMT stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge FDMT's true value.
Using relative valuations metrics:
- FDMT may be undervalued based on its P/B ratio of 0.29x, relative to Biotechnology industry P/B ratio of 4.37x
You can do additional valuation research on FDMT's stock here.
FDMT Financial Health Summary
Pros:
- FDMT has a low debt to equity ratio of 0.1.
- FDMT has cash burn of 138371000. It has sufficient cash and short-term investments to cover this for at least one year.
- Total FDMT debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the FDMT balance sheet.
- There are more short-term assets than long-term liabilities on the FDMT balance sheet.
- FDMT has $424.88M in cash and short term investments. This is sufficient to cover its annual cash burn of $138.37M.
Cons:
- FDMT profit margin has gone down from -486.6% to -434,778.4% in the past year.
Do analysts think it's a good time to buy 4d Molecular Therapeutics stock
Out of 6 Equities analysts who monitor FDMT, the consensus analyst rating on FDMT is a Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Latest FDMT Analyst Forecasts
Mani Foroohar, a bottom 2% analyst from Leerink Partners maintains FDMT with a buy rating and lowers their FDMT price target from $31.00 to $27.00, on Jan 13, 2025.
You can dig deeper into what analysts are saying on the 4d Molecular Therapeutics stock forecast page.
FDMT Trading Indicators
Is FDMT Making Money?
Last year, FDMT revenue was $37.00k. In the past five year, FDMT's revenue has grown by -64.94% per year. This was slower than the Biotechnology industry average of 45.47%.
You can analyze FDMT's earnings and revenue performance here.
Latest Insiders Trades at FDMT
Over the last 12 months, executives and large shareholders at FDMT have bought as many shares as they have sold.
Scott Bizily, Chief Legal Officer of FDMT, was the latest FDMT insider to sell. They sold $8,165.00 worth of FDMT stock on Sep 16, 2024.
Research more about who owns FDMT stock here.
Can I get consistent income from FDMT stock?
No, 4d Molecular Therapeutics doesn't provide an income stream by paying out dividends.
FDMT Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your FDMT trade
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at an exact price, use a limit order.
Click the Open Trade button and eToro will execute the order.
If you need more help investing in stocks on eToro, click the how to video below:
Step 6: Get the latest news on your FDMT investment
Now that you own some shares in FDMT, you'll want to keep up with your new stock purchase.
Make a watchlist to keep track of your FDMT stock.
FDMT Feed
How to Buy Stock in 4d Molecular Therapeutics
To reiterate, here are the 6 steps to buy stock in 4d Molecular Therapeutics:
- Decide where to buy 4d Molecular Therapeutics stock
- Create your brokerage account
- Put funds into your brokerage account
- Analyze 4d Molecular Therapeutics stock
- Make your FDMT trade
- Get the latest news on your FDMT investment
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you want to watch your new investment in 4d Molecular Therapeutics, add FDMT to your watchlist by clicking the button below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.